Kyowa Kirin Co (TSE:4151) Additional Paid-In Capital : 円464,708 Mil(As of Sep. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Additional Paid-In Capital?

Kyowa Kirin Co's quarterly additional paid-in capital increased from Mar. 2023 (円464,503 Mil) to Jun. 2023 (円464,663 Mil) and increased from Jun. 2023 (円464,663 Mil) to Sep. 2023 (円464,708 Mil).

Kyowa Kirin Co's annual additional paid-in capital increased from Dec. 2020 (円463,967 Mil) to Dec. 2021 (円464,153 Mil) and increased from Dec. 2021 (円464,153 Mil) to Dec. 2022 (円464,434 Mil).

Kyowa Kirin Co Additional Paid-In Capital Historical Data

The historical data trend for Kyowa Kirin Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Additional Paid-In Capital Chart

Kyowa Kirin Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

509,161.00

463,893.00

463,967.00

464,153.00

464,434.00

Kyowa Kirin Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Additional Paid-In Capital	Get a 7-Day Free Trial															464,345.00	464,434.00	464,503.00	464,663.00	464,708.00

Kyowa Kirin Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Kyowa Kirin Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyowa Kirin Co (TSE:4151) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

KYKOY:USA KYKOF:USA

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines